The Cancer

Don't Miss

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Elaine Riozzi Bodine and her daughter Alayna turned a life-altering analysis right into a mission to help different adolescents and younger adults with most cancers....

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

Vital Information

Facts

Latest Articles

A Liver Most cancers Journey Marked by Persistence, Household and Hope

For a lot of sufferers, the trail to a liver most cancers analysis is just not simple. Signs will be imprecise, assessments...

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

The U.S. Meals and Drug Administration (FDA) has granted Regenerative Medication Superior Remedy (RMAT) designation to KB707, an investigational inhaled immunotherapy being...

Knowledgeable Explains Adjuvant Temozolomide Boosts Astrocytoma Survival

Lengthy-term outcomes from the CATNON trial confirmed that including adjuvant temozolomide after radiotherapy considerably improved survival for sufferers with newly recognized IDH-mutant,...

Residing with IDH-Mutant Glioma: Understanding Prognosis, Therapy Choices and Supportive Care

In an interview for CURE Educated Affected person® Updates, Drs. Alexandra Miller, Daniel Orringer and Jonathan Yang mentioned how understanding analysis, biomarker...

Radiation Oncologist and Breast Most cancers Survivor Shares Her Story

Immediately, Dr. Sue Hwang went from a care supplier who had helped hundreds by way of their most cancers journeys to a...

Hot Topics